Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Other Non-Current Liabilities (2019 - 2022)

Historic Other Non-Current Liabilities for SELLAS Life Sciences (SLS) over the last 7 years, with Q3 2022 value amounting to $170000.0.

  • SELLAS Life Sciences' Other Non-Current Liabilities fell 9662.43% to $170000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $170000.0, marking a year-over-year decrease of 9662.43%. This contributed to the annual value of $296000.0 for FY2021, which is 9361.11% down from last year.
  • SELLAS Life Sciences' Other Non-Current Liabilities amounted to $170000.0 in Q3 2022, which was down 9662.43% from $181000.0 recorded in Q2 2022.
  • Over the past 5 years, SELLAS Life Sciences' Other Non-Current Liabilities peaked at $5.2 million during Q2 2020, and registered a low of $170000.0 during Q3 2022.
  • Its 4-year average for Other Non-Current Liabilities is $3.7 million, with a median of $4.8 million in 2019.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first soared by 800.75% in 2020, then crashed by 9662.43% in 2022.
  • Quarter analysis of 4 years shows SELLAS Life Sciences' Other Non-Current Liabilities stood at $4.9 million in 2019, then dropped by 5.68% to $4.6 million in 2020, then tumbled by 93.61% to $296000.0 in 2021, then crashed by 42.57% to $170000.0 in 2022.
  • Its Other Non-Current Liabilities stands at $170000.0 for Q3 2022, versus $181000.0 for Q2 2022 and $296000.0 for Q1 2022.